Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Schizophrenia Research

• Publication date

  2010-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.schres.2010.01.022PMID 20189356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia.

  2009cited by this paper
• Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.

  2009cited by this paper
• Working memory in schizophrenia: a meta-analysis

  2008cited by this paper
• Dynamic Regulation of Glutamatergic Postsynaptic Activity in Rat Prefrontal Cortex by Repeated Administration of Antipsychotic Drugs

  2008cited by this paper
• Switching schizophrenia patients from typical neuroleptics to olanzapine: effects on BOLD response during attention and working memory.

  2008cited by this paper
• The cognitive neuroscience of memory function and dysfunction in schizophrenia.

  2008cited by this paper
• Inefficient executive cognitive control in schizophrenia is preceded by altered functional activation during information encoding: an fMRI study.

  2008cited by this paper
• The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia.

  2008cited by this paper
• Anterior cingulate cortex and conflict detection: An update of theory and data

  2007cited by this paper
• Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory

  2007cited by this paper
• Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

  2007cited by this paper
• Dopamine D2 receptor occupancy levels of acute sulpiride challenges that produce working memory and learning impairments in healthy volunteers

  2007cited by this paper
• The role of extrastriatal dopamine D2 receptors in schizophrenia.

  2006cited by this paper
• Under the curve: critical issues for elucidating D1 receptor function in working memory.

  2006cited by this paper
• Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation

  2006cited by this paper
• The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine

  2006cited by this paper
• Functional connectivity reveals load dependent neural systems underlying encoding and maintenance in verbal working memory.

  2006cited by this paper
• First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients

  2006cited by this paper
• A functional MRI study of the effects of bromocriptine, a dopamine receptor agonist, on component processes of working memory

  2005cited by this paper
• A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

  2005cited by this paper
• N‐back working memory paradigm: A meta‐analysis of normative functional neuroimaging studies

  2005cited by this paper
• Beyond hypofrontality: A quantitative meta‐analysis of functional neuroimaging studies of working memory in schizophrenia

  2005cited by this paper
• Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement

  2005cited by this paper
• First- and second-generation antipsychotic medication and cognitive processing in schizophrenia

  2005cited by this paper
• Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI.

  2005cited by this paper
• Working memory impairments in schizophrenia: a meta-analysis.

  2005cited by this paper
• Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex.

  2005cited by this paper
• Dopamine Partial Agonists

  2004cited by this paper
• In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function.

  2004cited by this paper
• Clozapine but not Haloperidol Re-establishes Normal Task-Activated rCBF Patterns in Schizophrenia within the Anterior Cingulate Cortex

  2004cited by this paper
• Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.

  2004cited by this paper
• Identification of separable cognitive factors in schizophrenia.

  2004cited by this paper
• Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia.

  2004cited by this paper
• Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia

  2004cited by this paper
• Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine

  2003cited by this paper
• An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets

  2003cited by this paper
• Molecular brain imaging and the neurobiology and genetics of schizophrenia.

  2003cited by this paper
• Chlorpromazine equivalent doses for the newer atypical antipsychotics.

  2003cited by this paper
• Functional effects of antipsychotic drugs: comparing clozapine with haloperidol.

  2003cited by this paper
• The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia

  2002cited by this paper
• Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia.

  2002cited by this paper
• The computational role of dopamine D1 receptors in working memory

  2002cited by this paper
• Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

  2002cited by this paper
• Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia

  2002cited by this paper
• Elementary Signal Detection Theory

  2001cited by this paper
• 5‐HT2A and D2 receptor blockade increases cortical DA release via 5‐HT1A receptor activation: a possible mechanism of atypical antipsychotic‐induced cortical dopamine release

  2001cited by this paper
• Cognitive and emotional influences in anterior cingulate cortex.

  2000cited by this paper
• Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance.

  2000cited by this paper
• Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited.

  2000cited by this paper
• Automated Talairach Atlas labels for functional brain mapping

  2000cited by this paper
• A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo

  2000cited by this paper
• Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation.

  2000cited by this paper
• Emerging principles of altered neural circuitry in schizophrenia.

  2000cited by this paper
• NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders.

  1999cited by this paper
• Memory impairment in schizophrenia: a meta-analysis.

  1999cited by this paper
• Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.

  1999cited by this paper
• Neurotransmitter interactions in schizophrenia-therapeutic implications

  1999cited by this paper
• Physiological characteristics of capacity constraints in working memory as revealed by functional MRI.

  1999cited by this paper
• Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET.

  1999cited by this paper
• Neurotransmitter interactions in schizophrenia--therapeutic implications.

  1999cited by this paper
• Widespread origin of the primate mesofrontal dopamine system.

  1998cited by this paper
• Structured clinical interview for DSM-IV axis II personality disorders : SCID-II

  1997cited by this paper
• What are the functional consequences of neurocognitive deficits in schizophrenia?

  1996cited by this paper
• Dextroamphetamine Enhances “Neural Network-Specific” Physiological Signals: A Positron-Emission Tomography rCBF Study

  1996cited by this paper
• Brain imaging in schizophrenia.

  1995cited by this paper
• Modulation of memory fields by dopamine Dl receptors in prefrontal cortex

  1995cited by this paper
• Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia

  1995cited by this paper
• Statistical parametric maps in functional imaging: A general linear approach

  1994cited by this paper
• The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia

  1991cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Quantification of sleepiness: a new approach.

  1973cited by this paper
• The assessment and analysis of handedness: the Edinburgh inventory.

  1971cited by this paper

• Clinical response to treatment with a partial dopamine agonist is related to changes in reward processing.

  2023cites this paper
• Effect of aripiprazole on promoting cognitive function and enhancing clinical efficacy in patients with first-episode depression on escitalopram: A randomized controlled trial.

  2023cites this paper
• Working memory processing deficit associated with a nonlinear response pattern of the anterior cingulate cortex in first-episode and drug-naïve schizophrenia

  2022cites this paper
• Functional neurodevelopment of working memory in early-onset schizophrenia: A longitudinal FMRI study

  2022cites this paper
• Differential Effectiveness of Atypical Antipsychotics on Hallucinations

  2021cites this paper
• Effects of various antipsychotics on driving-related cognitive performance in adults with schizophrenia.

  2020cites this paper
• Prefrontal cortex activation during working memory task in schizophrenia: A fNIRS study.

  2020cites this paper
• Disparate effects of first and second generation antipsychotics on cognition in schizophrenia - Findings from the randomized NeSSy trial.

  2019cites this paper
• Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin

  2019cites this paper
• Neuroimaging and Antipsychotics

  2019cites this paper
• The relationship between dopamine receptor blockade and cognitive performance in schizophrenia: a [11C]-raclopride PET study with aripiprazole

  2018cites this paper
• Structural and functional alterations in the brain during working memory in medication-naïve patients at clinical high-risk for psychosis

  2018cites this paper
• Effects of aripiprazole versus risperidone on brain activation during planning and social-emotional evaluation in schizophrenia: A single-blind randomized exploratory study.

  2017cites this paper
• Functional Connectivity of Cognitive Brain Networks in Schizophrenia during a Working Memory Task

  2017cites this paper
• Modulation pharmacologique du raisonnement et de la prise de décision : apports pour la psychiatrie

  2017cites this paper
• Inhibition of the reward system by antipsychotic treatment

  2016cites this paper
• A negative relationship between ventral striatal loss anticipation response and impulsivity in borderline personality disorder

  2016cites this paper
• Effects of aripiprazole vs. haloperidol on brain activity in healthy volunteers

  2016cites this paper
• The effect of second-generation antipsychotics on hippocampal volume in first episode of psychosis: longitudinal study

  2016cites this paper
• Specific effect of a dopamine partial agonist on counterfactual learning: evidence from Gilles de la Tourette syndrome

  2016cites this paper
• Effect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI Studies

  2016cites this paper
• [Frontal brain volume reduction due to antipsychotic drugs?].

  2015cites this paper
• Primary prevention of psychosis through interventions in the symptomatic prodromal phase, a pragmatic Norwegian Ultra High Risk study

  2015cites this paper
• Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain.

  2015cites this paper
• Frontale Hirnvolumenminderung durch Antipsychotika?

  2015cites this paper
• Clinical Applications of fMRI

  2015cites this paper
• No difference in frontal cortical activity during an executive functioning task after acute doses of aripiprazole and haloperidol

  2015influential citation
• Frontale Hirnvolumen- minderung durch Antipsychotika?

  2015cites this paper
• Genetic modulation of working memory deficits by ankyrin 3 gene in schizophrenia.

  2014cites this paper
• Aripiprazole monotherapy can relieve ruminations in a case with nonpsychotic depression.

  2014cites this paper
• fMRI Investigations of the Mesolimbic Dopaminergic Reward System in Schizophrenia

  2014cites this paper
• Systematic review of the influence of antipsychotics on the blood oxygenation level-dependent signal of functional magnetic resonance imaging.

  2013cites this paper
• MULTIPLE MEMORY SYSTEMS IN PEOPLE WITH SCHIZOPHRENIA: POSSIBLE EFFECT OF ATYPICAL ANTI- PSYCHOTIC MEDICATIONS

  2013cites this paper
• Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: Clinical and neuroimaging evidence

  2013cites this paper
• Neuroimaging as a potential biomarker to optimize psychiatric research and treatment

  2013cites this paper
• Memory Deficits in Schizophrenia: A Selective Review of Functional Magnetic Resonance Imaging (fMRI) Studies

  2013cites this paper
• Cognitive effects of a single dose of atypical antipsychotics in healthy volunteers compared with placebo or haloperidol.

  2012cites this paper
• Subjective well-being of patients with schizophrenia as a target of drug treatment.

  2012cites this paper
• Imaging as tool to investigate psychoses and antipsychotics.

  2012cites this paper
• Reduced Prefrontal-Parietal Effective Connectivity and Working Memory Deficits in Schizophrenia

  2012cites this paper
• Bipolar disorder and cognitive functioning : a two-year naturalistic study

  2012cites this paper
• The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory

  2012cites this paper
• Prefrontal networks in schizophrenia: insights from neuroimaging

  2012influential citation
• Prefrontal networks in schizophrenia

  2012cites this paper
• Treatment effects in schizophrenia : evidence from neuroimaging

  2012cites this paper
• Antipsychotic medication and prefrontal cortex activation: a review of neuroimaging findings.

  2012cites this paper
• Dopamine Receptor Homooligomers and Heterooligomers in Schizophrenia

  2011cites this paper
• Antipsychotic dose and diminished neural modulation: a multi-site fMRI study.

  2011cites this paper
• Effectiveness of quetiapine in outpatients with schizophrenia assessed under "real-life" conditions: a German clinical-practice evaluation programme.

  2011cites this paper
• Improvement of cognitive flexibility and cingulate blood flow correlates after atypical antipsychotic treatment in drug-naive patients with first-episode schizophrenia.

  2011cites this paper
• Potential control of risperidone-related cognitive deficits by adjunctive aripiprazole treatment.

  2011cites this paper
• Neural activation and radial diffusivity in schizophrenia: combined fMRI and diffusion tensor imaging study.

  2011cites this paper
• Estudio del flujo sanguíneo regional cerebral con (99M)Tc-ECD SPECT durante una tarea de activación frontal antes y después del tratamiento con risperidona en pacientes con esquizofrenia no tratados previamente con neurolépticos

  2011cites this paper
• Qualifying brain functional MRI parameters as endophenotypes in schizophrenia

  2010cites this paper